GOCO — GoHealth Cashflow Statement
0.000.00%
Last trade - 00:00- $125.88m
- $736.00m
- $798.89m
Annual cashflow statement for GoHealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -97.2 | -534 | -376 | -151 | -7.32 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 237 | 434 | 60.1 | 38.5 | -45.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -352 | -306 | 270 | 116 | -74.9 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -114 | -299 | 60.9 | 109 | -21.6 |
| Capital Expenditures | -14.5 | -19.8 | -13.5 | -13.7 | -13.7 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | 17.5 |
| Sale of Business | |||||
| Cash from Investing Activities | -14.5 | -19.8 | -13.5 | -13.7 | 3.81 |
| Financing Cash Flow Items | -715 | -6.62 | -4.68 | -2.29 | -34.6 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 261 | 259 | -115 | -21.1 | -32 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 132 | -59.9 | -67.9 | 74.3 | -49.9 |